Telegram
NASDAQ: BGLC - BioNexus Gene Lab Corp.
Доходность за полгода: +45.72%
| Параметр | Оценка | Значение | Среднее по сектору | Разница с сектором, % | Средняя за 5 лет | Разница со средней, % |
|---|---|---|---|---|---|---|
| P/E |
|
0 | 46.23 | -100% | 350.8 | -100% |
P/E Forward 
|
|
0 | 350.8 | -100% | ||
| P/S |
|
0 | 9.94 | -100% | 15.99 | -100% |
| P/S Forward |
|
0 | 15.99 | -100% | ||
| P/BV |
|
0 | 6.91 | -100% | 27.96 | -100% |
| P/BV Forward |
|
0 | 27.96 | -100% | ||
| Ev/Ebitda |
|
-1 | 28.31 | -103.53% | -77.81 | -98.71% |
| Ev/Ebitda Forward |
|
-0.7461 | -77.81 | -99.04% |
